Background and Objective: Reports of multiple primary tumors are not n
ew. However, we have no ted a disproportionate number of patients with
melanoma in whom lymphoma develops and wanted to define the incidence
of this association. Design: All 664 patients with melanoma treated a
t Yale-New Haven Hospital, Conn, during the 5-year period from 1986 to
1991 were reviewed. The incidence of all the associated malignant neo
plasms among our patients with melanoma was compared with the incidenc
e that would be expected in the normal population adjusted for age, ra
ce, and sex. Results: Among the 664 patients, 54 (8.1%) had one or mor
e additional malignant neoplasms. Of the 10 different malignant tumor
types recorded, lymphomas were the most prevalent. This incidence of l
ymphoma among the melanoma patients was 12 of 664, resulting in an inc
idence of 548 per 100 000 population, 16 times higher (P<.0125) than t
he expected incidence (34 per 100 000) when adjusted for age, sex, and
race. Conclusions: The incidence of a second malignant neoplasm in ou
r patients with melanoma was 8.1%. Lymphoma was a particularly common
type of second malignancy, showing an incidence more than 16-fold high
er than that expected in the normal population. It is particularly imp
ortant, from a clinical point of view, to be aware of this when clinic
ally palpable lymph nodes develop in areas not normally the site of re
gional lymphatic drainage of the primary melanoma.